Giananthony Rizzo[email protected]Nuclear MedicineIs the U.S. due for a shortage of SPECT tracers? Part 2In the second part of our series on the coming shortage of SPECT radiopharmaceuticals, Giananthony Rizzo of Decision Resources Group examines other factors in the U.S. healthcare industry that could affect isotope prices in the future.November 17, 2016Nuclear MedicineIs the U.S. due for a shortage of SPECT tracers? Part 1A perfect storm is brewing in the global SPECT market that could see the prices of radiopharmaceuticals skyrocket over the next five years. A number of factors are coalescing that could lead to a shortage of SPECT tracers for years to come, according to this article by Giananthony Rizzo of Decision Resources Group.November 16, 2016Page 1 of 1Top StoriesMRIUnstable brain networks may drive multiple sclerosis fatigueFatigue affects between 36.5% and 78% of people with multiple sclerosis and can dramatically impair their daily lives.Womens ImagingAI-calculated BAC on mammograms predicts cardiovascular disease in womenCardiac ImagingECR: Cardiac imaging is at the 'heart' of precision medicineUltrasoundUltrasound MinnieCast, Episode 3: Focused ultrasound brings hope to patientsWomens ImagingECR: LLMs help patients understand breast imaging reports